Metraipolis › archive › dc_8a9686a89f9f

Thymalfasin combined with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: A retrospective study on efficacy, safety, and… — Europe PMC PMID:41994384

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41994384
DOI
10.12669/pjms.42.3.13385
License (as archived)
solo-consultazione
Archived
2026-11-05T11:46:54.120Z
SHA-256 of the archived text
a1673d2acd54bb045be570bfc686ad8ae03286be076ff88cc0bfecd61977fa17
Stable URL of this page
https://metraipolis.com/documento/dc_8a9686a89f9f

How to cite

Thymalfasin combined with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: A retrospective study on efficacy, safety, and… — Europe PMC PMID:41994384 — Europe PMC (en), https://europepmc.org/article/MED/41994384 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a9686a89f9f (Metraipolis archive dc_8a9686a89f9f, sha256 a1673d2acd54bb045be570bfc686ad8ae03286be076ff88cc0bfecd61977fa17)
BibTeX
@misc{dc8a9686a89f9f,
  title = {Thymalfasin combined with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: A retrospective study on efficacy, safety, and… — Europe PMC PMID:41994384},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41994384},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a9686a89f9f; sha256 a1673d2acd54bb045be570bfc686ad8ae03286be076ff88cc0bfecd61977fa17},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41994384. Agents can read the archived copy with the MCP tool read_document.